Hôpital Européen Georges Pompidou
About Hôpital Européen Georges Pompidou
The Hôpital Européen Georges-Pompidou is a French hospital located in Paris. The HEGP is under the aegis of the Assistance publique - Hôpitaux de Paris. Opened in 2001, the HEGP is the last-born Parisian hospital resulting from the merger of three older hospitals of the 15th district.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Assistance Publique - Hôpitaux de Paris
90
UNICANCER
27
Federation Francophone de Cancerologie Digestive
19
French Cardiology Society
15
Pfizer
14
Nantes University Hospital
13
GERCOR - Multidisciplinary Oncology Cooperative Group
11
University Hospital, Bordeaux
11
Boehringer Ingelheim
10
University Hospital, Brest
10
ARCAGY/ GINECO GROUP
9
Clinical Trials at Hôpital Européen Georges Pompidou
During the past decade, Hôpital Européen Georges Pompidou conducted 359 clinical trials. In the 10-year time frame, 359 clinical trials started and 57 clinical trials were completed, i.e. on
average, 15.9% percent of trials that started reached the finish line to date. In the past 5 years, 128 clinical trials started and 36 clinical trials were completed. i.e. 28.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
2000-09-01
Completed
36
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
2002-05-01
2010-09-01
Completed
195
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
2002-11-14
2022-12-31
Completed
413
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
2003-01-01
Completed
328
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
2003-04-01
Withdrawn
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpital Européen Georges Pompidou" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 90 trials, followed by "UNICANCER" with 27 trials
sponsored, "Federation Francophone de Cancerologie Digestive" with 19 trials sponsored, "French Cardiology Society" with 15 trials sponsored and "Pfizer"
with 15 trials sponsored. Other sponsors include 425 different institutions and
companies that sponsored additional 210 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Européen Georges Pompidou"
#1 collaborator was "Ministry of Health, France" with 26 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 15 trials as a collaborator, "European Georges Pompidou Hospital" with 11 trials as a collaborator, "National Cancer Institute, France" with 10 trials as a collaborator and "AstraZeneca" with 9 trials as a collaborator. Other collaborators include 377 different institutions and companies that were
collaborators in the rest 291 trials.
Clinical Trials Conditions at Hôpital Européen Georges Pompidou
According to Clinical.Site data, the most researched conditions in "Hôpital Européen Georges Pompidou" are
"Colorectal Cancer" (17 trials), "Ovarian Cancer" (16 trials), "Breast Cancer" (14 trials), "Prostate Cancer" (14 trials) and "Pulmonary Embolism" (13 trials). Many other conditions were trialed in "Hôpital Européen Georges Pompidou" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Européen Georges Pompidou
Most popular intervention types in "Hôpital Européen Georges Pompidou" are "Drug" (289 trials), "Other" (93 trials), "Device" (89 trials), "Procedure" (82 trials) and "Biological" (38 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (46 trials), "fluorouracil" (11 trials), "Bevacizumab" (10 trials), "Carboplatin" (9 trials) and "Gemcitabine" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Européen Georges Pompidou
The vast majority of trials in "Hôpital Européen Georges Pompidou" are
505 trials for "All" genders, 61 trials for "Female" genders and 29 trials for "Male" genders.
Clinical Trials Status at Hôpital Européen Georges Pompidou
Currently, there are 208 active trials in "Hôpital Européen Georges Pompidou".
6 are not yet recruiting,
136 are recruiting,
64 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 295 completed trials in Hôpital Européen Georges Pompidou,
1 suspended trials,
and 32 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Européen Georges Pompidou, 26 "Phase 1"
clinical trials were conducted, 121 "Phase 2" clinical
trials and 171 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 21 trials, and there were
also 140 trials that are defined as “Not Applicable".